In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in progressive supranuclear palsy

Gerhard, Alexander, Trender‐Gerhard, Iris, Turkheimer, Federico, Quinn, Niall P., Bhatia, Kailash P., Brooks, David J.·2006·Movement Disorders
DOI 10.1002/mds.20668

Cited by (171)

Items 101–171 of 171

  1. Lack of neuroinflammation in the HIV-1 transgenic rat: an [18F]-DPA714 PET imaging study
    Dianne E. Lee, Xuyi Yue, Wael G. Ibrahim, Margaret R. Lentz, Kristin L. Peterson, Elaine M. Jagoda, Michael Kassiou, Dragan Maric, William C. Reid, Dima A. Hammoud · 2015 · Journal of Neuroinflammation
  2. Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson’s Disease
    Bethany A. Grimmig, Josh M. Morganti, Kevin R. Nash, Paula C. Bickford · 2016 · Brain Sciences
  3. PET Neuroimaging in Dementia Conditions
    Daniela Perani, Silvia Paola Caminiti, Giulia Carli, Giacomo Tondo · 2020 · Springer eBooks
  4. Neurological update: neuroimaging in dementia
    Timothy Rittman · 2020 · Journal of Neurology
  5. Acid Sphingomyelinase Inhibition Mitigates Histopathological and Behavioral Changes in a Murine Model of Traumatic Brain Injury
    Grace M. Niziolek, Ryan M. Boudreau, Jennifer E. Baker, Lou Ann Friend, Amy Teres Makley, Michael J. Edwards, Erich Gulbins, Michael D. Goodman · 2020 · Journal of Neurotrauma
  6. Molecular imaging of movement disorders
    Karlo J. Lizárraga, Alessandra Augusta Gorgulho, Wei Chen, Antonio A. De Salles · 2016 · World Journal of Radiology
  7. Imaging neuroinflammation in Alzheimer’s and other dementias: recent advances and future directions
    David James Brooks · 2016 · Neurobiology of Aging
  8. The Cognitive Profile of Atypical Parkinsonism: A Meta-Analysis
    Simona Raimo, Mariachiara Gaita, Maria Cropano, Giusi Mautone, Alfonsina D’Iorio, Luigi Trojano, Gabriella Santangelo · 2022 · Neuropsychology Review
  9. Tracing the History of the Human Translocator Protein to Recent Neurodegenerative and Psychiatric Imaging
    Olivia M. Downer, Rachel E.G. Marcus, Nicole R. Zürcher, Jacob M. Hooker · 2020 · ACS Chemical Neuroscience
  10. PET Imaging to Measure Neuroinflammation In Vivo
    Maura Malpetti, Nicolai Franzmeier, Matthias Brendel · 2024 · Methods in molecular biology
  11. Peripheral immune profile and neutrophil‐to‐lymphocyte ratio in progressive supranuclear palsy: Case–control study and meta‐analysis
    Laura Muñoz‐Delgado, Antonio Cristóbal Luque-Ambrosiani, Belén Benítez Zamora, Daniel Macías‐García, Silvia Jesús, Astrid Daniela Adarmes-Gómez, Elena Ojeda‐Lepe, Fátima Carrillo, Pablo Mir · 2024 · European Journal of Neurology
  12. Positron Emission Tomography for Brain Research
    Masahiro Mishina · 2008 · Journal of Nippon Medical School
  13. New Imaging Markers for Movement Disorders
    Christine Ghadery, Antonio P. Strafella · 2018 · Current Neurology and Neuroscience Reports
  14. Effects of bromelain on striatal neuroinflammation in rat model of Parkinsonism
    Temitope Samson Adu, Musa Vuyisile Mabandla · 2021 · Brain Disorders
  15. Image Quantification for TSPO PET with a Novel Image-Derived Input Function Method
    Yu-Hua Dean Fang, Jonathan McConathy, Talene A. Yacoubian, Yue Zhang, Richard Kennedy, David G. Standaert · 2022 · Diagnostics
  16. Brainstem and cerebellar radiological findings in progressive supranuclear palsy
    Chloe Spiegel, Cassandra Marotta, Kelly Bertram, Lucy E. Vivash, Ian H. Harding · 2024 · Brain Communications
  17. Progress in the treatment of Parkinson-Plus syndromes
    Nahid Olfati, Ali Shoeibi, Irene Litvan · 2018 · Parkinsonism & Related Disorders
  18. PET Molecular Imaging in Atypical Parkinsonism
    Zheyu Xu, Javier Arbizu, Nicola Pavese · 2018 · International review of neurobiology
  19. Zolpidem in Progressive Supranuclear Palsy
    Sandip K. Dash · 2013 · Case Reports in Neurological Medicine
  20. Enhanced phosphorylation of T153 in soluble tau is a defining biochemical feature of the A152T tau risk variant
    Yari Carlomagno, Dah‐eun Chloe Chung, Mei Yue, Aishe Kurti, Nicole M. Avendano, Monica Castanedes‐Casey, Kelly M. Hinkle, Karen R. Jansen‐West, Lillian M. Daughrity, Jimei Tong et al. · 2019 · Acta Neuropathologica Communications
  21. Imaging of Neuroinflammation in Parkinsonian Syndromes with Positron Emission Tomography
    Alexander Gerhard · 2013 · Current Neurology and Neuroscience Reports
  22. Milestones in neuroimaging
    A. Jon Stoessl, David James Brooks, David Eidelberg · 2011 · Movement Disorders
  23. In vivo Assessment of Neuroinflammation in 4-Repeat Tauopathies
    Carla Palleis, Julia Sauerbeck, Leonie Beyer, Stefanie Harris, Julia Schmitt, Estrella Morenas‐Rodríguez, Anika Finze, Alexander Nitschmann, François Ruch, Florian Eckenweber et al. · 2020 · medRxiv
  24. Why Therapeutic Trials Fail in Primary Tauopathies
    Nahid Olfati, Hamidreza Ghodsi, Ece Bayram, Irene Litvan · 2023 · Movement Disorders
  25. The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer’s Disease
    Kiran Bhaskar, Bruce T. Lamb · 2011 · Springer eBooks
  26. Neuroinflammation in Movement Disorders
    Elena Saavedra-López, Paola V. Casanova, George Paul Cribaro, Carlos Barcia · 2016 · Handbook of behavioral neuroscience
  27. The Inflammatory Mechanism of Parkinson’s Disease: Gut Microbiota Metabolites Affect the Development of the Disease Through the Gut–Brain Axis
    Ai Gao, Jiaqi Lv, Yanwei Su · 2025 · Brain Sciences
  28. Loss of Metabotropic Glutamate Receptor 5 Function on Peripheral Benzodiazepine Receptor in Mice Prenatally Exposed to LPS
    Dany Arsenault, Katherine Coulombe, Aijun Zhu, Chunyu Gong, Kun-Eek Kil, Ji‐Kyung Choi, Pekka Poutiainen, Anna‐Liisa Brownell · 2015 · PLoS ONE
  29. Perspectives in TSPO PET Imaging for Neurologic Diseases
    Yoo Sung Song · 2019 · Nuclear Medicine and Molecular Imaging
  30. Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsy
    Noah Lorenz Shapiro, Peter Simon Jones, Elijah Mak, Kamen A. Tsvetanov, Julia Goddard, Davi S Vontobel, Robert Durcan, Leonidas Chouliaras, Tim D. Fryer, Young T. Hong et al. · 2025 · Brain Communications
  31. Therapeutic options for Progressive Supranuclear Palsy including investigational drugs
    Ali Shoeibi, Irene Litvan · 2017 · Expert Opinion on Orphan Drugs
  32. Multireceptor fingerprints in progressive supranuclear palsy
    Wang Zheng Chiu, Laura Donker Kaat, Agnita J.W. Boon, Wouter Kamphorst, Axel Schleicher, Karl Zilles, John Cornelis Van Swieten, Nicola Palomero‐Gallagher · 2017 · Alzheimer s Research & Therapy
  33. CSF1R inhibitor levels determine sex-specific phenotype of resilient microglia and neurofunctional rescue leading to extended survival in tauopathy mice
    Noah R. Johnson, Peng Yuan, Erika Castillo, T. Peter Lopez, Weizhou Yue, Annalise Bond, Brianna M. Rivera, Miranda C. Sullivan, Masakazu Hirouchi, Kurt Giles et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  34. Diagnostic utility of biomarkers in progressive supranuclear palsy: toward a biotyping framework
    Christine B. Ryan, Christian J. Camargo, Teddy Salan, Suresh Pallikkuth, Hanzhi Gao, Varan Govind · 2025 · Journal of Neurology
  35. The Panomics Approach in Neurodegenerative Disorders
    B. Szatmári, Péter Balicza, György Németh, Mária Judit Molnár · 2019 · Current Medicinal Chemistry
  36. PET Imaging of Translocator Protein Expression in Neurological Disorders
    David James Brooks · 2020 · Springer eBooks
  37. Common variation at the LRRK2 locus is associated with survival in the primary tauopathy progressive supranuclear palsy
    Edwin Jabbari, Manuela M. X. Tan, Regina Hertfelder Reynolds, Kin Ying Mok, Raffaele Ferrari, David P. Murphy, Rebecca R. Valentino, Owen A. Ross, Dennis W. Dickson, Safa Al‐Sarraj et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Distinct 11C-ER176 PET Neuroinflammatory Profiles and Tau Colocalization in Progressive Apraxia of Speech With and Without Parkinson-plus Syndrome
    Ryota Satoh, Rene L. Utianski, Joseph R. Duffy, Heather M. Clark, Yehkyoung C. Stephens, Jeyeon Lee, Matt C. Baker, Rosa Rademakers, Val J. Lowe, Keith A. Josephs et al. · 2025 · Clinical Nuclear Medicine
  39. Microglial Imaging in Movement Disorders With PK11195 PET
    Seong‐Beom Koh · 2008 · Journal of Movement Disorders
  40. The challenging quest of neuroimaging: From clinical to molecular-based subtyping of Parkinson disease and atypical parkinsonisms
    Sanskriti Sasikumar, Antonio P. Strafella · 2023 · Handbook of clinical neurology
  41. Impact of Partial Volume Correction on [18F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome
    Sebastian Schuster, Leonie Beyer, Carla Palleis, Stefanie Harris, Julia Schmitt, Endy Weidinger, Catharina Prix, Kai Bötzel, Adrian Danek, Boris‐Stephan Rauchmann et al. · 2022 · Brain Sciences
  42. SPECT/PET Findings in Lewy Body Dementia
    Rhiannon Ducksbury, Tim J Whitfield, Zuzana Walker · 2014 · Springer eBooks
  43. Neuroinflammation and Parkinson’s Disease
    Francisco Ros‐Bernal, J. E. Yuste, Ernesto Tarragón, V. Ortiz, A. Gómez, C. M. Ros, Emiliano Fernández‐Villalba, María Trinidad Herrero · 2014 · Springer eBooks
  44. SPECT and PET in Atypical Parkinsonism
    John Peter Seibyl · 2010 · PET Clinics
  45. Corticobasal Degeneration
    M. Niethammer · 2021 · Hybrid PET/MR Neuroimaging
  46. PET Imaging of Translocator Protein Expression in Neurological Disorders
    David James Brooks · 2014 · Springer eBooks
  47. Movement Disorders: Focus on Parkinson’s Disease and Related Disorders
    Andrea Varrone, Sabina Pappatà, Mario Quarantelli · 2016 · Springer eBooks
  48. PET and SPECT Imaging in Parkinsonian Syndromes
    Chris C. Tang, Martin Niethammer, Patricia J. Allen, Klaus Leonhard Leenders, David Eidelberg · 2014 · Springer eBooks
  49. Proteopathic Tau Primes and Activates Interleukin-1ß(Il-1ß) via MyD88- and NLRP3-ASC-Inflammasome Dependent Pathways
    Shanya Jiang, Nicole M. Maphis, Jessica Binder, Devon Chisholm, Lea L. Weston, Walter Duran, Crina M. Floruta, Amber J. Zimmerman, Stephen D. Jett, Eileen H. Bigio et al. · 2019 · SSRN Electronic Journal
  50. New Perspectives in Nuclear Neurology for the Evaluation of Parkinson's Disease
    Marcel Benadiba, Gert Luurtsema, Vítor Tumas, Carlos Alberto Buchpiguel, Geraldo F. Busatto · 2013 · Journal of Parkinson s Disease
  51. Diagnosis and Management of Progressive Supranuclear Palsy
    Lawrence I. Golbe · 2013 · Neurodegenerative Disease Management
  52. Design of a deuterated TSPO tracer and its application in glioma and atherosclerotic imaging
    Yong Huang, Zeng Jiang, Lu Zhang, Ziyue Yu, Chengze Li, Hualong Chen, Ying Liang, Zehui Wu · 2024 · New Journal of Chemistry
  53. PET Imaging of Microglia Activation in Neuropsychiatric Disorders with Potential Infectious Origin
    Hans Christiaan Klein, Lot D. de Witte, Robert C. Bransfield, Peter Paul De Deyn · 2014 · Springer eBooks
  54. Rubor, calor, tumor, dolor, functio laesa… or molecular imaging
    Giovanni Lucignani · 2007 · European Journal of Nuclear Medicine and Molecular Imaging
  55. PET and SPECT Imaging in Atypical Parkinsonian Syndromes
    Martin Niethammer, Yoon Young Choi, Chris C. Tang, David Eidelberg · 2020 · Springer eBooks
  56. PET Imaging of Microglia Activation and Infection in Neuropsychiatric Disorders with Potential Infectious Origin
    Hans Christiaan Klein, Lot D. de Witte, Robert C. Bransfield, Peter Paul De Deyn · 2020 · Springer eBooks
  57. Progressive Supranuclear Palsy and Corticobasal Degeneration: Similarities and Differences
    Pratap Chand, Irene Litvan · 2008 · Future Neurology
  58. Distribution physiologique cérébrale et corps entier du 18F-DPA-714 en TEP/TDM
    Benoit Erra, Johnny Vercouillie, Philippe Corcia, S. Maïa, Nicolas Arlicot, J.-L. Baulieu, Denis Guilloteau, Maria-João Ribeiro · 2013 · Médecine Nucléaire
  59. Molecular imaging in dementia
    Alexander E. Drzezga, Alexander Kurz · 2008 · European Journal of Nuclear Medicine and Molecular Imaging
  60. PET Imaging in Neuroinflammation
    David James Brooks · 2014 · Springer eBooks
  61. Review Article Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease
    Edward C. Lauterbach · 2016
  62. Central Nervous System Imaging in Movement Disorders
    Matteo Bauckneht, Silvia Chiola, Maria Isabella Donegani, Stefano Raffa, Alberto Miceli, Giulia Ferrarazzo, Silvia Daniela Morbelli · 2021 · Elsevier eBooks
  63. Dementia
    2023 · Advances in magnetic resonance technology and applications
  64. Neuroinflammation Imaging in Neurodegenerative Diseases
    Dima A. Hammoud, Peter Herscovitch · 2023 · Springer eBooks
  65. A Practical Guide to Metabolic and Molecular Imaging in Atypical Parkinsonism
    Christian Dresel · 2024 · Neuromethods
  66. Magnetic Resonance Imaging in the Neuroimaging of Progressive Supranuclear Palsy—Parkinsonism Predominant: Limitations and Strengths in Clinical Evaluation
    Piotr Alster, Michał Kutyłowski, Natalia Madetko‐Alster · 2025 · Diagnostics
  67. Fluid and Imaging Markers of Glial Reactivity
    Marc Suárez‐Calvet · 2025 · Springer eBooks
  68. Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsy
    Noah Lorenz Shapiro, Peter Simon Jones, Elijah Mak, Kamen A. Tsvetanov, Julia Goddard, Davi S Vontobel, Robert Durcan, Leonidas Chouliaras, Tim D. Fryer, Young T. Hong et al. · 2025 · medRxiv
  69. Imagerie moléculaire de la neuroinflammation : evaluation préclinique d'un nouveau radiopharmaceutique : le CLINDE.
    Nicolas Arlicot · 2009
  70. From clinical phenotypes to molecular precision: multimodal biomarkers for progressive supranuclear palsy
    Glenn A. Harris, Lymor Barnhard, Jennifer Brummet, Kristophe Diaz · 2026 · Frontiers in Neuroscience
  71. The characteristics of perivascular proinflammation in 4‐repeat tauopathies
    Mu‐Hui Fu, Gӧkhan Uruk, Rodolfo G. Gatto, Robert Ross Reichard, Jennifer Louise Whitwell, Keith A. Josephs · 2026 · Brain Pathology